Status:
COMPLETED
Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre
Lead Sponsor:
New Brunswick Heart Centre
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
Brief Summary
In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction account...
Eligibility Criteria
Inclusion
- 1\) Any patient admitted to the CCU with a diagnosis of CS (SCAI groups C, D or E) at any point during their CCU care.
Exclusion
- 1\) CS patients having SCAI groups A, B (this group was used only for preliminary analysis, hence this is the exclusion criteria for all final analyses).
Key Trial Info
Start Date :
January 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 13 2021
Estimated Enrollment :
1416 Patients enrolled
Trial Details
Trial ID
NCT05414643
Start Date
January 14 2021
End Date
October 13 2021
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Brunswick Heart Centre
Saint John, New Brunswick, Canada, E2L 4L2